| 000 | 01456 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250517222703.0 | ||
| 264 | 0 | _c20200625 | |
| 008 | 202006s 0 0 eng d | ||
| 022 | _a1476-5578 | ||
| 024 | 7 |
_a10.1038/s41380-018-0083-8 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWray, Nathan H | |
| 245 | 0 | 0 |
_aNMDAR-independent, cAMP-dependent antidepressant actions of ketamine. _h[electronic resource] |
| 260 |
_bMolecular psychiatry _c12 2019 |
||
| 300 |
_a1833-1843 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. | ||
| 650 | 0 | 4 |
_aAntidepressive Agents _xpharmacology |
| 650 | 0 | 4 |
_aBrain-Derived Neurotrophic Factor _xmetabolism |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 |
_aCyclic AMP _xmetabolism |
| 650 | 0 | 4 |
_aCyclic AMP Response Element-Binding Protein _xmetabolism |
| 650 | 0 | 4 |
_aDepression _xdrug therapy |
| 650 | 0 | 4 |
_aGlioma _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aKetamine _xpharmacology |
| 650 | 0 | 4 |
_aMembrane Microdomains _xdrug effects |
| 650 | 0 | 4 |
_aReceptors, N-Methyl-D-Aspartate _xmetabolism |
| 700 | 1 | _aSchappi, Jeffrey M | |
| 700 | 1 | _aSingh, Harinder | |
| 700 | 1 | _aSenese, Nicolas B | |
| 700 | 1 | _aRasenick, Mark M | |
| 773 | 0 |
_tMolecular psychiatry _gvol. 24 _gno. 12 _gp. 1833-1843 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/s41380-018-0083-8 _zAvailable from publisher's website |
| 999 |
_c28523720 _d28523720 |
||